Introduction to NMR and Its Application in Metabolite Structure Determination

Drug Metabolism in Drug Design and Development: Basic Concepts and Practice

Volumn , Issue , 2007, Pages 369-409

  Huang, Xiaohua ^a   Powers, Robert ^b   Tymiak, Adrienne ^a   Espina, Robert ^c   Roongta, Vikram ^a  

^a BRISTOL MYERS SQUIBB   (United States)

^b UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^c PFIZER INC   (United States)

Author keywords

Chemically nonequivalent nuclei; Multiple bond heteronuclear coupling constants; Solvent suppression techniques

Indexed keywords

EID: 69249105418     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470191699.ch12     Document Type: Chapter

References (61)

1. Albert K. Online use of NMR detection in separation chemistry. J Chromatogr A 1995;703:123-147.
2. Alexander AJ, Xu F, Bernard C. The design of a multidimensional LC-SPE-NMR system (LC2-SPE-NMR) for complex mixture analysis. Magn Reson Chem 2006;44(1):1-6.
3. Basker MJ, Finch SC, Tyler JW. Use of 1H NMR in the identification of a metabolite of a catecholic cephalosporin excreted in rat bile. J Pharm Biomed Anal 1990;8:573-576.
4. Berger S, Braun S. 200 and More NMR Experiments. second ed. John Wiley & Sons; 2004.
5. Betz M, Saxena K, Schwalbe H. Biomolecular NMR: a chaperone to drug discovery. Curr Opin Chem Biol 2006;10(3):219-225.
6. Bieri S, Varesio E, Veuthey JL, Muñoz O, Tseng LH, Braumann U, Spraul M, Christen P. Identification of isomeric tropane alkaloids from Schizanthus grahamii by HPLC-NMR with loop storage and HPLC-UV-MS/SPE-NMR using a cryogenic flowprobe. Phytochem Anal 2006;17(2):78-86.
7. Borlak J, Walles M, Elend M, Thum T, Preiss A, Levsen K. Verapamil: identification of novel metabolites in cultures of primary human hepatocytes and human urine by LC-MS(n) and LC-NMR. Xenobiotica 2003;33(6):655-676.
8. Breitmaier E. Structure Elucidation by NMR in Organic Chemistry: A Practical Guide. Third ed. John Wiley & Sons; 2002.
9. Bruker Biospin GmbH. Bruker BioSpin announces novel capillary LC-NMR system 2002. Forthcoming.
10. Buker Biospin GmbH. Bruker BioSpin introduces the CryoFlowProbe, the world's first cryogenic flow-injection NMR probe 2002. Forthcoming, Available at http://www.bruker-biospin.com/nmr/news/pdf_files/cryoflowprb.pdf.
11. Chando TJ, Everett DW, Kahle AD, Starrett AM, Vachharajani N, Shyu WC, Kripalani KJ, Barbhaiya RH. Biotransformation of irbesartan in man. Drug Metab Dispos 1998;26:408-417.
12. Chen H, Shockcor J, Chen W, Espina R, Gan LS,Mutlib AE. Delineating novel metabolic pathways of DPC 963, a nonnucleoside reverse transcriptase inhibitor, in rats. Characterization of glutathione conjugates of postulated oxirene and benzoquinone imine intermediates by LC-MS and LC-NMR. Chem Res Toxicol 2002;15:388-399.
13. Corcoran O, Spraul M. LC-NMR-MS in drug discovery. Drug Discov Today 2003;8(14):624-631.
14. Dagnino-Subiabre A, Cassels BK, Baez S, Johansson AS, Mannervik B, Segura-Aguilar J. Glutathione transferase M2-2 catalyzes conjugation of dopamine and dopa O-quinones. Biochem Biophys Res Commun 2000;274:32-36.
15. Daykin CA, VanDuynhoven JPM, Groenewegen A, Dachtler M, Van Amelsvoort JMM, Mulder TPJ. Nuclear magnetic resonance spectroscopic based studies of the metabolism of black tea polyphenols in humans. J Agric Food Chem 2005;53:1428-1434.
16. Exarchou V, Godejohann M, van Beek TA, Gerothanassis IP, Vervoort J. LC-UV-solid-phase extraction-NMR-MS combined with a cryogenic flow probe and its application to the identification of compounds present in Greek oregano. Anal Chem 2003;75(22):6288-6294.
17. Exarchou V, Krucker M, van Beek TA, Vervoort J, Gerothanassis IP, Albert K. LC-NMR coupling technology: recent advancements and applications in natural products analysis. Magn Reson Chem 2005;43(9):681-687.
18. Freeman R, A Handbook of Nuclear Magnetic Resonance. second ed. Longman Publishing Group; 1997.
19. Friebolin H, Basic One-and Two-Dimensional NMR Spectroscopy. fourth ed. John Wiley & Sons; 2005.
20. Froehlich AK, Girreser D, Clement B. Metabolism of N-hydroxyguanidines (N-hydroxydebrisoquine) in human and porcine hepatocytes: reduction and formation of glucuronides. Drug Metabo Dispos 2005;33:1532-1537.
21. Gaggelli E, Valensin G. Methods of single-and double-selective excitation: theory and applications. Part II. Conc Magn Reson 1993;5(1):19-42.
22. Garcia GE, Hicks RP, Skanchy D, Moorad-Doctor DR, Doctor BP, Ved HS. Identification and characterization of the major huperzine a metabolite in rat blood. J Anal Toxicol 2004;28:379-383.
23. Gerhard U, Thomas S, Mortishire-Smith R. Accelerated metabolite identification by ''extraction-NMR''. J Pharm Biomed Anal 2003;32:531-538.
24. Godejohann M, Tseng LH, Braumann U, Fuchser J, Spraul M. Characterization of a paracetamol metabolite using on-line LC-SPE-NMR-MS and a cryogenic NMR probe. J Chromatogr A 2004;1058(1-2):191-196.
25. Hajduk PJ. SAR by NMR: putting the pieces together. Mol Interv 2006;6(5):266-272.
26. Homans SW. A Dictionary of Concepts in NMR. Second ed. Oxford University Press; 2005.
27. Hwang TL, Shaka AJ. Water suppression that works. Excitation sculpting using arbitrary wave-forms and pulsed-field gradients. J Magn Reson Series A 1995;112(2):275-279.
28. Iwasa K, Kuribayashi A, Sugiura M, Moriyasu M, Lee DU, Wiegrebe W. LC-NMR and LC-MS analysis of 2,3,10,11-oxygenated protoberberine metabolites in Corydalis cell cultures. Phytochemistry 2003;64(7):1229-1238.
29. Jairaj M, Watson DG, Grant MH, Gray AI, Skellern GG. Comparative biotransformation of morphine, codeine and pholcodine in rat hepatocytes: identification of a novel metabolite of pholcodine. Xenobiotica 2002;32:1093-1107.
30. Keeler J. Understanding NMR Spectroscopy. first ed. UK: John Wiley and Sons; 2005.
31. Keun HC, Beckonert O, Griffin JL, Richter C, Moskau D, Lindon JC, Nicholson JK. Cryogenic probe 13C NMR spectroscopy of urine for metabonomic studies. Anal Chem 2002;74:4588-4593.
32. Klaus A. On-line LC-NMR and Related Techniques, first ed. E-Book;2003.
33. Kupee E. NMR at 900 MHz. Chem Heter Comp 2001;37(11):1429-1438.
34. Lepre CA, Moore JM, Peng JW. Theory and applications of NMR-based screening in pharmaceutical research. Chem Rev 2004:104(8):3641-76
35. Lindon JC, Nicholson JK, Wilson ID. The development and application of coupled HPLC-NMR spectroscopy. Adv Chromatogr 1996;36:315-382.
36. Lyčka A, Fryšová I, Slouka J. An anomalous course of the reduction of 2-(3-oxo-3,4-dihydroquinoxalin-2-yl)benzene diazonium salt: a reinvestigation. Magn Reson Chem 2007;45(1):46-50.
37. Martin G, Zektzer A, Two-Dimensional NMR Methods for Establishing Molecular Connectivity. First ed. VCH; New York: 1998.
38. Moreno A, Daz-Ortiz A, Dez-Barra E, de la Hoz A, Langa F, Prieto P, Claridge TDW. Determination of the stereochemistry of four spirodiastereoisomers by one-and twodimensional NOE studies. Magn Reson Chem 1996;34(1):52-58.
39. Munro SLA, Craik DJ. NMR conformational studies of fenamate non-steroidal antiinflammatory drugs. Magn Reson Chem 1994;32(6):335-342.
40. NMR probes. Varian Inc, Palo Alto, CA, USA;2002. Available at http://www.varianinc.com/cgi-bin/nav?varinc/docs/nmr/products/probes.
41. Orry AJ, Abagyan RA, Cavasotto CN. Structure-based development of target-specific compound libraries. Drug Discov Today 2006;11(5-6):261-266.
42. Pellecchia M. Solution nuclear magnetic resonance spectroscopy techniques for probing intermolecular interactions. Chem Biol 2005;12(9):961-971.
43. Reilly CA, Ehlhardt WJ, Jackson DA, Kulanthaivel P, Mutlib AE, Espina RJ, Moody DE, Crouch DJ, Yost GS. Metabolism of capsaicin by cytochrome P450 produces novel dehydrogenated metabolites and decreases cytotoxicity to lung and liver cells. Chem Res Toxicol 2003;16(3):336-349.
44. Schaefer M, Faller P, Nicole D. Regio-and stereoselective alkylation of a pyrrolidinic system: structural and conformational studies by high field NMR techniques. Org Magn Reson 1982;19(2):108-111.
45. Schlotterbeck G, Ross A, Hochstrasser R, Senn H, Kuhn T, Marek D, Schett O. Highresolution capillary tube NMR. A miniaturized 5 mL high-sensitivity TXI probe for mass-limited samples, off-line LC NMR, and HT NMR. Anal Chem 2002;74:4464-4471.
46. Schutz A, Golbik R, Konig S, Hubner G, Tittmann K. Intermediates and transition states in thiamin diphosphate-dependent decarboxylases. A kinetic and NMR study on wild-type indolepyruvate decarboxylase and variants using indolepyruvate, benzoylformate, and pyruvate as substrates. Biochemistry 2005;26:44916):6164-79.
47. Seger C, Godejohann M, Spraul M, Stuppner H, Hadacek F. Reaction product analysis by high-performance liquid chromatography-solid-phase extraction-nuclear magnetic resonance Application to the absolute configuration determination of naturally occurring polyyne alcohols. J Chromatogr A 2006;1136(1):82-88.
48. Sem DS, Pellecchia M. NMR in the acceleration of drug discovery. Curr Opin Drug Discov Devel 2001;4(4):479-492.
49. Shockcor PJ, Unger SH, Wilson ID, Foxall PJD, Nicholson JK, Lindon JC. Combined hyphenation of HPLC, NMR spectroscopy and ion trap mass spectrometry (LC-NMR-MS) with application to the detection and characterization of xenobiotic and endogenous metabolites in human urine. Anal Chem 1996;68:4431-4435.
50. Smallcombe SH, Patt SL. WET solvent suppression and its applications to LC-NMR and high-resolution NMR spectroscopy. J Magn Reson Series A 1995;117(2):295-303.
51. Spraul M, Hofmann M, Lindon JC, Farrant RD, Seddon MJ, Nicholson JK, Wilson ID. Evaluation of liquid-chromatography coupled with high-field 1H NMR spectroscopy for drug metabolite detection and characterization: the identification of paracetamol metabolites in urine and bile. NMR Biomed 1994;7:295-303.
52. Spraul M, Hofmann M, Dvortsak P, Nicholson JK, Wilson ID. High-performance liquid chromatography coupled to high-field proton nuclear magnetic resonance spectroscopy: application to the urinary metabolites of ibuprofen. Anal Chem 1993;65:327-330.
53. Spraul M, Freund AS, Nast RE, Withers RS, Maas WE, Corcoran O. Advancing NMR sensitivity for LC-NMR-MS using a cryoflow probe: application to the analysis of acetaminophen metabolites in urine. Anal Chem 2003;75(6):1536-1541.
54. Sridharan V, Saravanan S, Muthusubramanian S, Sivasubramanian S. NMR investigation of hydrogen bonding and 1,3-tautomerism in 2-(2-hydroxy-5-substituted-aryl) benzimidazoles. Magn Reson Chem 2005;43(7):551-556.
55. Valente AP, Miyamoto CA, Almeida FC. Implications of protein conformational diversity for binding and development of new biological active compounds. Curr Med Chem 2006;13(30):3697-3703.
56. Wilson SR, Malerd H, Petersen D, Simic N, Bobu MM, Rise F, Lundanes E, Greibrokk T. Controlling LC-SPE-NMR systems. J Sep Sci 2006;29(4):582-589.
57. Xu F, Alexander AJ. The design of an on-line semipreparative LC-SPE-NMR system for trace analysis. Magn Reson Chem 2005;43(9):776-782.
58. Yang Z. Online hyphenated liquid chromatography-nuclear magnetic resonance spectroscopy-mass spectrometry for drug metabolite and nature product analysis. J Pharm Biomed Anal 2006;40(3):516-527.
59. Zartler ER, Shapiro MJ. Protein NMR-based screening in drug discovery. Curr Pharm Des 2006;12(31):3963-3972.
60. Zhang D, Zhao W, Roongta VR, Mitroka JG, Klunk LJ, Zhu M. Amide Nglucuronidation of MaxiPost catalyzed by UDP-glucuronosyltransferase 2B7 in humans. Drug Metab Dispos 2004;32:545-551.
61. Zhou CC, Hill DR. The keto-enol tautomerization of ethyl butylryl acetate studied by LC-NMR. Magn Reson Chem 2006;45(2):128-132.